Go to Samples
Verzenio 50mg sample image

Eli Lilly and Co.

Verzenio

28 x 50mg oral tablets per box

Indications and Usage

VERZENIO® is a kinase inhibitor.

Available in Tablets: 50 mg, 100 mg, 150 mg, and 200 mg provided as immediate-release oval white, beige, or yellow tablets indicated to be taken with or without food twice daily with a recommended and approved starting dose of 150mg for combination therapy or 200mg for monotherapy.

Early Breast Cancer

VERZENIO® (abemaciclib) is indicated:

  • in combination with endocrine therapy (tamoxifen or an aromatase inhibitor) for the adjuvant treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, node-positive, early breast cancer at high risk of recurrence [see Clinical Studies ].

Advanced or Metastatic Breast Cancer

VERZENIO (abemaciclib) is indicated:

  • in combination with an aromatase inhibitor as initial endocrine-based therapy for the treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer.
  • in combination with fulvestrant for the treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer with disease progression following endocrine therapy.
  • as monotherapy for the treatment of adult patients with HR-positive, HER2-negative advanced or metastatic breast cancer with disease progression following endocrine therapy and prior chemotherapy in the metastatic setting.
More than 200,000 clinicians have integrated PrescriberPoint into their clinical workflows
Novant
Mayo
Duke
PANN
Ohio
Novant
Mayo
Duke
PANN
Ohio

HOW IT WORKS

The easy way to access samples

Confirm EligibilitySamples are available for authorized US healthcare providers
Create Free AccountRequest, track, and manage samples from multiple brands
Get your SampleSamples shipped directly to your practice door
Want to check your eligibility to order samples?

WHO IS PRESCRIBERPOINT

Increasing patient access to medications they need

At PrescriberPoint, we're revolutionizing how healthcare providers get patients the medications they need. We craft solutions that help providers address the challenges in patient access and improve outcomes.
200K+Visitors Each Month
100K+Engagements Each Month
1M+Resources Viewed

WHAT HCPS ARE SAYING

This tool has transformed the way we order drug samples. Not having to interact with reps has saved us so much time and hassle. Plus, the ability to track orders in real-time is incredibly convenient. Our patients benefit greatly from the streamlined processCardiologistSan Francisco, CA
We can't imagine going back to the old way of ordering samples. The seamless integration with our existing systems and the timely scheduled deliveries have made our workflow so much more efficient. Our patients are receiving better care thanks to this tool.PediatricianChicago, IL
Ordering samples is now a breeze! The interface is user-friendly, and scheduling deliveries has never been easier. This tool has truly enhanced our patient care by ensuring they get the medications they need promptly.Family PhysicianAustin, TX

FAQs

All you need to know to order samples

Currently, PrescriberPoint is available only in the U.S, but we are excited to expand our reach in the future! Stay connected by following us or signing up for our newsletter to get the latest updates, including announcements about new market launches.